OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sequence-based drug design as a concept in computational drug design
Lifan Chen, Zisheng Fan, Jie Chang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 79

Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis
Zhenhui Wu, Shupeng Chen, Yihao Wang, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 13

Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery
Xiaochu Tong, Ning Qu, Xiangtai Kong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10

Mitochondrial Sirtuins in Cancer: A Revisited Review from Molecular Mechanisms to Therapeutic Strategies
Hui Shen, Wei Ma, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2993-3013
Open Access | Times Cited: 6

Artificial intelligence in drug development
Kang Zhang, Xin Yang, Yifei Wang, et al.
Nature Medicine (2025) Vol. 31, Iss. 1, pp. 45-59
Closed Access

Bridging Traditions and Technology: The Role of Ethnopharmacology in Shaping Next‐Generation Multidisciplinary Researchers
Ee Wern Tan, Lori Low, Atanas G. Atanasov, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access

Agents for the Treatment of Gout: Current Advances and Future Perspectives
Xiaoyi Zeng, Yajing Liu, Yuxin Fan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14474-14493
Closed Access | Times Cited: 19

Drug discovery and development in the era of artificial intelligence: From machine learning to large language models
Shenghui Guan, Guanyu Wang
Artificial Intelligence Chemistry (2024) Vol. 2, Iss. 1, pp. 100070-100070
Open Access | Times Cited: 5

In silico off-target profiling for enhanced drug safety assessment
Jin Liu, Yike Gui, Jingxin Rao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2927-2941
Open Access | Times Cited: 4

Hydrophobic tagging of small molecules: an overview of the literature and future outlook
Yang Zhou, Fan Zhou, Shujing Xu, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 7, pp. 799-813
Closed Access | Times Cited: 4

DrugReAlign: a multisource prompt framework for drug repurposing based on large language models
Jinhang Wei, Linlin Zhuo, Xiangzheng Fu, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

A review of transformers in drug discovery and beyond
Jian Jiang, Long Chen, Ke Lü, et al.
Journal of Pharmaceutical Analysis (2024), pp. 101081-101081
Open Access | Times Cited: 3

Structural Relationships to Efficacy for Prazole‐Derived Antivirals
David A. Nyenhuis, Susan M. Watanabe, Rebecca Bernstein, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 3

Development of small molecule drugs targeting immune checkpoints
Luoyi Chen, Xinchen Zhao, Xiaowei Liu, et al.
Cancer Biology and Medicine (2024), pp. 1-18
Open Access | Times Cited: 3

Conformational Space Profiling Enhances Generic Molecular Representation for AI‐Powered Ligand‐Based Drug Discovery
Lin Wang, Shihang Wang, Hao Yang, et al.
Advanced Science (2024) Vol. 11, Iss. 40
Open Access | Times Cited: 3

Chemical language models for molecular design
Jürgen Bajorath
Molecular Informatics (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 9

HBCVTr: an end-to-end transformer with a deep neural network hybrid model for anti-HBV and HCV activity predictor from SMILES
Ittipat Meewan, Jiraporn Panmanee, Nopphon Petchyam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Generative design of compounds with desired potency from target protein sequences using a multimodal biochemical language model
Hengwei Chen, Jürgen Bajorath
Journal of Cheminformatics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Identifying compound-protein interactions with knowledge graph embedding of perturbation transcriptomics
Shengkun Ni, Xiangtai Kong, Yingying Zhang, et al.
Cell Genomics (2024), pp. 100655-100655
Open Access | Times Cited: 2

Ginkgetin Alleviates Inflammation and Senescence by Targeting STING
Yadan Liu, Jialin Ye, Zisheng Fan, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 2

Extension of multi-site analogue series with potent compounds using a bidirectional transformer-based chemical language model
Hengwei Chen, Atsushi Yoshimori, Jürgen Bajorath
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2527-2537
Closed Access | Times Cited: 1

DRML-Ensemble: drug repurposing method based on feature construction of multi-layer ensemble
Mengfei Zhang, Hongjian He, Jiang Xie, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 8
Closed Access | Times Cited: 1

Mixture-of-Experts Approach for Enhanced Drug-Target Interaction Prediction and Confidence Assessment
Yijingxiu Lu, Sangseon Lee, Soosung Kang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top